Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 82

1.

Effect of Granulocyte Colony-Stimulating Factor-Combined Conditioning in Cord Blood Transplantation for Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia: A Retrospective Study in Japan.

Konuma T, Takahashi S, Uchida N, Kuwatsuka Y, Yamasaki S, Aoki J, Onishi Y, Aotsuka N, Ohashi K, Mori T, Masuko M, Nakamae H, Miyamura K, Kato K, Atsuta Y, Kato S, Asano S, Takami A, Miyazaki Y; Adult Myelodysplastic Syndrome and Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2015 Sep;21(9):1632-40. doi: 10.1016/j.bbmt.2015.05.009. Epub 2015 May 16.

PMID:
25985920
2.

Long-term outcomes of granulocyte colony-stimulating factor-combined conditioning in allogeneic hematopoietic stem cell transplantation from HLA-identical family donors for myeloid malignancies.

Konuma T, Kato S, Ishii H, Oiwa-Monna M, Asano S, Tojo A, Takahashi S.

Leuk Res. 2015 Jun;39(6):625-31. doi: 10.1016/j.leukres.2015.03.022. Epub 2015 Apr 7.

PMID:
25888304
3.

Donald Metcalf, 'Father of CSF' (1929-2014).

Asano S.

Int J Hematol. 2015 Mar;101(3):209-10. doi: 10.1007/s12185-015-1753-9. No abstract available.

PMID:
25708314
4.

Granulocyte colony-stimulating factor combined regimen in cord blood transplantation for acute myeloid leukemia: a nationwide retrospective analysis in Japan.

Konuma T, Ooi J, Uchida N, Ogawa H, Ohashi K, Kanamori H, Aotsuka N, Onishi Y, Yamaguchi H, Kozai Y, Nagamura-Inoue T, Kato K, Suzuki R, Atsuta Y, Kato S, Asano S, Takahashi S.

Haematologica. 2014 Dec;99(12):e264-8. doi: 10.3324/haematol.2014.114504. Epub 2014 Sep 12. No abstract available.

5.

Single-unit cord blood transplantation after granulocyte colony-stimulating factor-combined myeloablative conditioning for myeloid malignancies not in remission.

Konuma T, Kato S, Ooi J, Oiwa-Monna M, Ebihara Y, Mochizuki S, Yuji K, Ohno N, Kawamata T, Jo N, Yokoyama K, Uchimaru K, Asano S, Tojo A, Takahashi S.

Biol Blood Marrow Transplant. 2014 Mar;20(3):396-401. doi: 10.1016/j.bbmt.2013.12.555. Epub 2013 Dec 11.

6.

FGF7 supports hematopoietic stem and progenitor cells and niche-dependent myeloblastoma cells via autocrine action on bone marrow stromal cells in vitro.

Ishino R, Minami K, Tanaka S, Nagai M, Matsui K, Hasegawa N, Roeder RG, Asano S, Ito M.

Biochem Biophys Res Commun. 2013 Oct 11;440(1):125-31. doi: 10.1016/j.bbrc.2013.09.044. Epub 2013 Sep 16.

PMID:
24051090
7.

A versatile drug delivery system using streptavidin-tagged pegylated liposomes and biotinylated biomaterials.

Chen MH, Soda Y, Izawa K, Kobayashi S, Tani K, Maruyama K, Tojo A, Asano S.

Int J Pharm. 2013 Sep 15;454(1):478-85. doi: 10.1016/j.ijpharm.2013.06.031. Epub 2013 Jun 24.

PMID:
23806815
8.

Current status of hematopoietic stem cell transplantation for acute radiation syndromes.

Asano S.

Int J Hematol. 2012 Mar;95(3):227-31. doi: 10.1007/s12185-012-1027-8. Epub 2012 Mar 3. Review.

PMID:
22382644
9.

Unrelated cord blood transplantation after myeloablative conditioning regimen in adolescent and young adult patients with hematologic malignancies: a single institute analysis.

Ebihara Y, Takahashi S, Mochizuki S, Kato S, Kawakita T, Ooi J, Yokoyama K, Nagamura F, Tojo A, Asano S, Tsuji K.

Leuk Res. 2012 Feb;36(2):128-31. doi: 10.1016/j.leukres.2011.09.016. Epub 2011 Oct 5.

PMID:
21982638
10.

Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population.

Tanabe T, Yamaguchi N, Matsuda K, Yamazaki K, Takahashi S, Tojo A, Onizuka M, Eishi Y, Akiyama H, Ishikawa J, Mori T, Hara M, Koike K, Kawa K, Kawase T, Morishima Y, Amano H, Kobayashi-Miura M, Kakamu T, Nakamura Y, Asano S, Fujita Y.

Int J Hematol. 2011 Jun;93(6):771-8. doi: 10.1007/s12185-011-0860-5. Epub 2011 May 15.

PMID:
21573891
11.

Adhesion-induced drug resistance in leukemia stem cells.

Funayama K, Murai F, Shimane M, Nomura H, Asano S.

Pharmacology. 2010;86(2):79-84. doi: 10.1159/000305344. Epub 2010 Aug 6. Erratum in: Pharmacology. 2010;86(4):202.

PMID:
20689339
12.

Adhesion-mediated self-renewal abilities of Ph+ blastoma cells.

Funayama K, Saito-Kurimoto Y, Ebihara Y, Shimane M, Nomura H, Tsuji K, Asano S.

Biochem Biophys Res Commun. 2010 May 28;396(2):193-8. doi: 10.1016/j.bbrc.2010.03.172. Epub 2010 Apr 1.

PMID:
20362549
13.

An evidence for adhesion-mediated acquisition of acute myeloid leukemic stem cell-like immaturities.

Funayama K, Shimane M, Nomura H, Asano S.

Biochem Biophys Res Commun. 2010 Feb 12;392(3):271-6. doi: 10.1016/j.bbrc.2009.12.163. Epub 2010 Jan 12.

PMID:
20060807
14.

Unrelated cord blood transplantation after myeloablative conditioning in adults with acute myelogenous leukemia.

Ooi J, Takahashi S, Tomonari A, Tsukada N, Konuma T, Kato S, Kasahara S, Sato A, Monma F, Nagamura F, Iseki T, Tojo A, Asano S.

Biol Blood Marrow Transplant. 2008 Dec;14(12):1341-7. doi: 10.1016/j.bbmt.2008.09.007.

15.

Myeloablative unrelated cord blood transplantation for acute leukemia patients between 50 and 55 years of age: single institutional retrospective comparison with patients younger than 50 years of age.

Konuma T, Takahashi S, Ooi J, Tomonari A, Tsukada N, Kato S, Sato A, Monma F, Kasahara S, Nagamura-Inoue T, Uchimaru K, Iseki T, Tojo A, Yamaguchi T, Asano S.

Ann Hematol. 2009 Jun;88(6):581-8. doi: 10.1007/s00277-008-0641-2. Epub 2008 Nov 22.

PMID:
19030858
16.

Second myeloablative allogeneic stem cell transplantation (SCT) using cord blood for leukemia relapsed after initial allogeneic SCT.

Konuma T, Ooi J, Takahashi S, Tomonari A, Tsukada N, Kato S, Sato A, Monma F, Kasahara S, Uchimaru K, Iseki T, Tojo A, Asano S.

Leuk Res. 2009 Jun;33(6):840-2. doi: 10.1016/j.leukres.2008.10.003. Epub 2008 Nov 7.

PMID:
18995897
17.

Early renal injury after myeloablative cord blood transplantation in adults.

Mae H, Ooi J, Takahashi S, Tomonari A, Tsukada N, Konuma T, Hongo E, Kato S, Kasahara S, Oiwa-Monna M, Kurokawa Y, Tojo A, Asano S.

Leuk Lymphoma. 2008 Mar;49(3):538-42. doi: 10.1080/10428190701824577.

PMID:
18297532
18.

Myeloablative unrelated cord blood transplantation for adult acute myeloid leukemia patients with 11q23 abnormalities.

Konuma T, Ooi J, Takahashi S, Tomonari A, Tsukada N, Kato S, Kasahara S, Uchimaru K, Iseki T, Tojo A, Asano S.

Eur J Haematol. 2008 Jun;80(6):545-8. doi: 10.1111/j.1600-0609.2008.01057.x. Epub 2008 Feb 12. No abstract available.

PMID:
18284623
19.

Impact of cytomegalovirus serostatus on outcome of unrelated cord blood transplantation for adults: a single-institute experience in Japan.

Tomonari A, Takahashi S, Ooi J, Tsukada N, Konuma T, Kato S, Kasahara S, Iseki T, Yamaguchi T, Tojo A, Asano S.

Eur J Haematol. 2008 Mar;80(3):251-7. Epub 2007 Dec 7.

PMID:
18081702
20.

Bacterial bloodstream infection in neutropenic adult patients after myeloablative cord blood transplantation: experience of a single institution in Japan.

Tomonari A, Takahashi S, Ooi J, Tsukada N, Konuma T, Kobayashi T, Sato A, Takasugi K, Iseki T, Tojo A, Asano S.

Int J Hematol. 2007 Apr;85(3):238-41.

PMID:
17483061
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk